Anti-tumor immunotherapy using engineered bacterial outer membrane vesicles fused to lysosome-targeting chimeras mediated by transferrin receptor
- PMID: 39721580
- DOI: 10.1016/j.chembiol.2024.12.008
Anti-tumor immunotherapy using engineered bacterial outer membrane vesicles fused to lysosome-targeting chimeras mediated by transferrin receptor
Erratum for
-
Anti-tumor immunotherapy using engineered bacterial outer membrane vesicles fused to lysosome-targeting chimeras mediated by transferrin receptor.Cell Chem Biol. 2024 Jun 20;31(6):1219-1230.e5. doi: 10.1016/j.chembiol.2024.01.002. Epub 2024 Feb 2. Cell Chem Biol. 2024. PMID: 38309277
Publication types
LinkOut - more resources
Full Text Sources
